Back to Trades
Astley-Sparke Philip
DirectorCIK 0001376491
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 2
- Active
- 2025–2026
Across 5 filings between 2025–2026, Astley-Sparke Philip, Director, has disclosed $887.0K in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $89.7K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Aug 24 | REPL Replimune Group, Inc. | Astley-Sparke Philip | Director | Gift | $0 |
| Jun 17 | ENGN enGene Therapeutics Inc. | Astley-Sparke Philip | Insider | Award | $54.3K |
| May 20 | REPL Replimune Group, Inc. | Astley-Sparke Philip | Director | Sell | $89.7K |
| Apr 7 | REPL Replimune Group, Inc. | Astley-Sparke Philip | Director | Grant | $570.8K |
| Jul 10 | ENGN enGene Holdings Inc. | Astley-Sparke Philip | Insider | Award | $172.3K |
5 filings